COVID-19 and Liver Diseases, What We Know So Far

Overview

Journal World J Clin Cases

Publisher Baishideng Publishing Group

Specialty General Medicine

Date 2022 Jun 6

PMID 35665122

Authors

Mohamed Elnaggar

Ahmed Abomhya

Ismail Elkhattib

Nabila Dawoud

Rajkumar Doshi

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID-19) pneumonia outbreak started in December 2019. On March 12, 2020, the World Health Organization (WHO) declared that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) constitutes a pandemic, and as of May 2021, SARS-CoV-2 has infected over 167.3 million patients, including 3.4 million deaths, reported to WHO. In this review, we will focus on the relationship between SARS-CoV-2 infection and the liver. We will discuss how chronic liver diseases affect the COVID-19 disease course and outcomes. We will also discuss the SARS-CoV-2 effects on the liver, mechanisms of acute liver injury, and potential management plans.

Citing Articles

New Insights into the Effects of SARS-CoV-2 on Metabolic Organs: A Narrative Review of COVID-19 Induced Diabetes.

Li L, Li L, Cai X, Pan Z Diabetes Metab Syndr Obes. 2024; 17:1383-1389.

PMID: 38529167 PMC: 10962470. DOI: 10.2147/DMSO.S454408.

Altered Liver Biochemistry and Mortality in Patients Hospitalized With COVID-19.

Munoz Rossi F, Gallo Orjuela D, Guaiquil A, Gonzalez C, Salazar Agudelo J, Quinapanta Castro N Cureus. 2024; 16(2):e54218.

PMID: 38496100 PMC: 10943261. DOI: 10.7759/cureus.54218.

An Updated Systematic Review and Meta-Analysis of the Association between the De Ritis Ratio and Disease Severity and Mortality in Patients with COVID-19.

Mangoni A, Zinellu A Life (Basel). 2023; 13(6).

PMID: 37374107 PMC: 10303964. DOI: 10.3390/life13061324.

Effect of SARS-CoV-2 infection on the liver.

Sanyaolu A, Marinkovic A, Abbasi A, Prakash S, Patidar R, Desai P World J Virol. 2023; 12(2):109-121.

PMID: 37033147 PMC: 10075054. DOI: 10.5501/wjv.v12.i2.109.

COVID-19 and liver injury: An ongoing challenge.

Papagiouvanni I, Kotoulas S, Pataka A, Spyratos D, Porpodis K, Boutou A World J Gastroenterol. 2023; 29(2):257-271.

PMID: 36687117 PMC: 9846934. DOI: 10.3748/wjg.v29.i2.257.

References

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G . A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382(19):1787-1799. PMC: 7121492. DOI: 10.1056/NEJMoa2001282. View

Tapper E, Robson S, Malik R . Coagulopathy in cirrhosis - the role of the platelet in hemostasis. J Hepatol. 2013; 59(4):889-90. DOI: 10.1016/j.jhep.2013.03.040. View

Liang W, Guan W, Chen R, Wang W, Li J, Xu K . Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21(3):335-337. PMC: 7159000. DOI: 10.1016/S1470-2045(20)30096-6. View

Arvaniti V, DAmico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M . Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010; 139(4):1246-56, 1256.e1-5. DOI: 10.1053/j.gastro.2010.06.019. View

Qian Q, Fan L, Liu W, Li J, Yue J, Wang M . Direct Evidence of Active SARS-CoV-2 Replication in the Intestine. Clin Infect Dis. 2020; 73(3):361-366. PMC: 7454471. DOI: 10.1093/cid/ciaa925. View

Zhou Y, Ding F, Bao W, Xue Y, Han L, Zhang X . Clinical features in coronavirus disease 2019 (COVID-19) patients with early clearance and prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. Ann Transl Med. 2021; 9(8):665. PMC: 8106067. DOI: 10.21037/atm-21-445. View

Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G . Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2006; 17(7):517-24. DOI: 10.1016/j.numecd.2006.04.002. View

Fan V, Dominitz J, Eastment M, Locke E, Green P, Berry K . Risk Factors for Testing Positive for Severe Acute Respiratory Syndrome Coronavirus 2 in a National United States Healthcare System. Clin Infect Dis. 2020; 73(9):e3085-e3094. PMC: 7665412. DOI: 10.1093/cid/ciaa1624. View

Galanopoulos M, Gkeros F, Doukatas A, Karianakis G, Pontas C, Tsoukalas N . COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol. 2020; 26(31):4579-4588. PMC: 7445869. DOI: 10.3748/wjg.v26.i31.4579. View

10.

Greenough T, Carville A, Coderre J, Somasundaran M, Sullivan J, Luzuriaga K . Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus. Am J Pathol. 2005; 167(2):455-63. PMC: 1603565. DOI: 10.1016/S0002-9440(10)62989-6. View

11.

Grgurevic I, Podrug K, Mikolasevic I, Kukla M, Madir A, Tsochatzis E . Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach. Can J Gastroenterol Hepatol. 2020; 2020:9181368. PMC: 6995480. DOI: 10.1155/2020/9181368. View

12.

Chan J, Kok K, Zhu Z, Chu H, To K, Yuan S . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9(1):221-236. PMC: 7067204. DOI: 10.1080/22221751.2020.1719902. View

13.

Chornenkyy Y, Mejia-Bautista M, Brucal M, Blanke T, Dittmann D, Yeldandi A . Liver Pathology and SARS-CoV-2 Detection in Formalin-Fixed Tissue of Patients With COVID-19. Am J Clin Pathol. 2021; 155(6):802-814. PMC: 8135761. DOI: 10.1093/ajcp/aqab009. View

14.

Horwitz L, Jones S, Cerfolio R, Francois F, Greco J, Rudy B . Trends in COVID-19 Risk-Adjusted Mortality Rates. J Hosp Med. 2020; 16(2):90-92. DOI: 10.12788/jhm.3552. View

15.

Yip T, Wong V, Lui G, Chow V, Tse Y, Hui V . Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID-19. Hepatology. 2021; 74(4):1750-1765. PMC: 8239872. DOI: 10.1002/hep.31890. View

16.

Colmenero J, Rodriguez-Peralvarez M, Salcedo M, Arias-Milla A, Munoz-Serrano A, Graus J . Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol. 2020; 74(1):148-155. PMC: 7395653. DOI: 10.1016/j.jhep.2020.07.040. View

17.

Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q . Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int. 2020; 40(9):2095-2103. DOI: 10.1111/liv.14455. View

18.

Sun H, Zhang J, Zhang H, Zou Z, Wang F, Jia J . Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat. 2012; 19(6):396-403. DOI: 10.1111/j.1365-2893.2011.01561.x. View

19.

Zhao J, Zhou G, Sun Y, Wang S, Yang J, Meng E . [Clinical pathology and pathogenesis of severe acute respiratory syndrome]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004; 17(3):217-21. View

20.

Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052-2059. PMC: 7177629. DOI: 10.1001/jama.2020.6775. View